Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma - Concepedia

Concepedia

Publication | Open Access

Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma

DOI Full Paper Access

64

Citations

17

References

2022

Year

Brian I. Rini, Sabina Signoretti, Toni K. Choueiri, David F. McDermott, Robert J. Motzer, Saby George, Thomas Powles, Frede Donskov, Scott S. Tykodi, Sumanta K. Pal,

Journal for ImmunoTherapy of Cancer

Abstract

NCT02231749.

References

	Year	Citations

Page 1